STAAR Surgical CEO Farrell to step down Jan 31; Broadwood appoints three new directors

STAAR SURGICAL CO

CEO Stephen Farrell to step down as CEO by Jan 31, 2026; will remain as consultant for 1 year at $45k/month.
Board expands from 6 to 7; Neal Bradsher and Richard LeBuhn (Broadwood, 31% owner) and Christopher Wang (Yunqi Capital, 6.5%) appointed.
Elizabeth Yeu resigns as Board Chair and director; Board seeks new Chair and CEO.
NASDAQ audit committee noncompliance due to Yeu resignation; Company using cure period.
Cooperation agreement includes standstill until June 18, 2026; mutual non-disparagement.

item 1.01item 3.01item 5.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.